glp 1 cost australia Who Shouldn't Be On GLP-1 Medications? & Sustainability The GLP-1 RA boom: Trends

GDF15 Macrophage inhibitory cytokine 1 (MIC1

10.1146/annurev.nutr.26.061505.111258 Annu Rev Nutr

Thirdly , theres also a patent application (IN202047010224) (pdf) pending by Novo Nordisk, filed in 2020 with priority date of 24/08/2017, for a specific formulation of semaglutide (the active ingredient in its commercial blockbuster drug, Ozempic) described as Semaglutide liquid formulations (no more than 0.01% (w/w) phenol. Adding to the complexity is a recent revocation petition filed by DRL in May 2025 (as reported by the media here)

That process takes months and requires a sustained record of compliance

While green tea may have benefits, a closer look at this study suggests the news was exaggerated and misleading